In our community learning session with Giray Görbil (Clinical Marketing Coordinator at Cyntegrity), we explored the fascinating connection between the "Law of Attraction and the Power of Imagination". These two concepts, when combined, can unlock new ways of thinking, creating, and shaping our personal [...]
In today’s global market, success isn’t just about offering a great product or service it’s about connecting with people from different cultures in a meaningful way. The latest Community Learning Session with Julien Goncalves (Head of Growth at Cyntegrity) shared valuable insights during his [...]
EMA's new Clinical Trials Map transforms overwhelming trial data into actionable geographic insights. Anastasia, Cyntegrity's Head of Centralized Monitoring, explains why this intuitive map is essential for smarter, data-driven recruitment strategies.
The latest Community Learning Session with our CEO, Artem Andrianov took us into the world of AI-driven automation, focusing on how AI Automation & Productivity and other AI tools can streamline workflows, reduce manual effort, and enhance productivity. Automating Repetitive Tasks AI can handle [...]
Discover how the finalized ICH E6(R3) guideline elevates site and sponsor collaboration, emphasizing robust training, resource allocation, and digitally empowered data governance.
Communication Skills: Speaking for Effect Do you ever feel like your words don’t land the way you intend? Maybe you’ve shared an idea, but the reaction wasn’t what you expected. Communication isn’t just about speaking it’s about making sure your message is understood [...]
Do You Set Goals? How Do You Keep Them in Sight? Some people write their goals in a notebook, others use digital trackers, post-it notes, or vision boards. But what really works to stay on track? That was the focus of our latest [...]
The ICH E6(R3) guideline was formally adopted on January 6, 2025, introducing reinforced principles for clinical trial conduct. This final version builds on its draft with clarified expectations and some notable revisions. Let’s explore the highlights and the implications for stakeholders.
With ICH E6(R3) reinforcing proactive quality management, relying on EDC systems with hundreds of edit checks is impractical. The MyRBQM Portal bridges the gap with predictive analytics, historical data views, and real-time risk drill-downs, enhancing oversight and reducing complexity. Learn how EDC and RBQM work together for more insightful, compliant trial management.
The ICH E6(R3) guideline redefines expectations for clinical trial sites, emphasizing proactive planning, data accuracy, and risk monitoring to enhance participant safety and trial efficiency. Download our presentation for practical insights and strategies to ensure compliance and strengthen collaboration.
